Skip to main content
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
- Christina Sæten Fjeldbo
- Tord Hompland
- Tiril Hillestad
- Eva-Katrine Aarnes
- Clara-Cecilie Günther
Publication details
-
Journal:
EBioMedicine, vol. 57, p. 0, 2020
-
Publisher:
Elsevier
-
International Standard Numbers:
- Printed: 2352-3964
- Electronic: 2352-3964
-
Links:
- You are here: Home
- Publications
- Scientific article
- Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity